Bayat Nooshin, Farashi Samaneh, Hafezi-Nejad Nima, Faramarzi Negin, Ashki Mehri, Vakili Shadi, Imanian Hashem, Khosravi Mohsen, Azar-Keivan Azita, Najmabadi Hossein
Kariminejad-Najmabadi Pathology & Genetics Centre, Tehran, Iran.
Hemoglobin. 2013;37(2):148-59. doi: 10.3109/03630269.2013.763821. Epub 2013 Feb 12.
α-Thalassemia (α-thal) is usually caused by deletions on the α-globin gene cluster and the role of point mutations is less well investigated. In the present study, a total of 1048 individuals with hypochromic microcytic anemia, who did not present the most common α-thal deletions, were referred for α-globin gene DNA sequencing. The nucleotide changes were studied and a total of five new mutations was identified, of which three were located on the α2 gene [codon7 (Lys→Stop), codon 34 (Leu→Pro) and codon 83 (Leu→Arg)] and two on the α1 gene [IVS-I-116 (A>G) and codon 44 (+C)]. These novel mutations not only explain new findings by molecular analysis of the α-globin gene but also have clinical importance due to their changes in α-globin production in means of decreased hemoglobin (Hb) related values. Moreover, considerations of its role in combination with other mutations, and the possibility of causing Hb H (β4) are yet to be studied.
α地中海贫血(α-thal)通常由α珠蛋白基因簇的缺失引起,而点突变的作用研究较少。在本研究中,共有1048例低色素小细胞贫血患者被转诊进行α珠蛋白基因DNA测序,这些患者不存在最常见的α-thal缺失。对核苷酸变化进行了研究,共鉴定出5个新突变,其中3个位于α2基因上[密码子7(赖氨酸→终止密码子)、密码子34(亮氨酸→脯氨酸)和密码子83(亮氨酸→精氨酸)],2个位于α1基因上[内含子I-116(A>G)和密码子44(+C)]。这些新突变不仅通过α珠蛋白基因的分子分析解释了新发现,而且由于它们通过降低血红蛋白(Hb)相关值改变了α珠蛋白的产生,因而具有临床重要性。此外,其与其他突变联合作用的角色以及导致Hb H(β4)的可能性仍有待研究。